Alterity Therapeutics (ATHE) Other Non-Current Liabilities (2017 - 2024)

Alterity Therapeutics has reported Other Non-Current Liabilities for 8 years, with the latest figure at $28197.3 in Q4 2024.

• For the quarter ending Q4 2024, Other Non-Current Liabilities fell 43.38% year-over-year to $28197.3; the trailing twelve-month figure through Dec 2024 stood at $28197.3 (down 43.38% YoY), and the FY2024 full-year result was $34212.6, up 162.47% from the prior year.
• Other Non-Current Liabilities for Q4 2024 stood at $28197.3, down from $34212.6 in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $49804.0 in Q4 2023, with the low at -$2.0 million in Q2 2021.
• Average Other Non-Current Liabilities over 5 years is -$353595.6, with a median of $19272.4 recorded in 2022.
• Year-over-year, Other Non-Current Liabilities tumbled 5726.92% in 2020 and surged 162.47% in 2024.
• Tracing ATHE's Other Non-Current Liabilities over 5 years: stood at -$1.4 million in 2020, then soared by 101.41% to $19470.6 in 2021, then slipped by 1.02% to $19272.4 in 2022, then surged by 158.42% to $49804.0 in 2023, then plunged by 43.38% to $28197.3 in 2024.
• The last three Other Non-Current Liabilities figures came in at $28197.3 (Q4 2024), $34212.6 (Q2 2024), and $49804.0 (Q4 2023), per Business Quant data.

Peer Comparison